Depression Drugs News Monitoring

Neumora plummets on depression drug data

Neumora Therapeutics, a well-funded biotechnology company, lost more than 80% of its value Thursday because its most advanced drug failed a major test. After seeing positive signs in a smaller study in 2023, Neumora pushed the drug into a trio of late- …

Results are in for a new depression drug trial, and they're cratering this stock

Neumora Therapeutics Stock Tanks as Its Depression Drug Misses Goals

Thomas Trutschel / Photothek via Getty Images Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged. The biopharmaceutical firm's navacaprant treatment failed to reach both primary and …

Results are in for a new depression drug trial, and they're cratering this stock

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, fell short of expectations in a late-stage clinical trial, disappointing Wall Street.Read more...

Mass. biotech stock plunges after depression drug fails late-stage trial

Neumora’s Novel Depression Drug Strikes Out in First Pivotal Trial

The downward trend set in depression in 2024 continued into the New Year as Neumora Therapeutics reported that its highly anticipated major depressive disorder candidate navacaprant failed the first of three Phase III trials. A kappa opioid receptor (KOR) …

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops

Neumora Therapeutics (NMRA) stock collapsed Thursday after its experimental depression treatment failed in the first of three studies planned by the biotech company. ↑ X NOW PLAYING How To Sell Stocks: When To Cut Losses In the study called Koastal-1, …

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials

On Thursday, Neumora Therapeutics, Inc. NMRA stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study of navacaprant for major depressive disorder. The KOASTAL-1 Study is the first of three replicate Phase 3 studies that comprise …

Neumora Therapeutics’ depression drug fails to meet main goal of late-stage study

Neumora Therapeutics said on Thursday its experimental drug to treat depression failed to meet the main goal of a late-stage study, sending shares of the company down 82% in premarket trading. The study, first of the three late-stage trials, was testing …

Neumora Plunges After Major Depression Drug Fails in Study

(Bloomberg) -- Neumora Therapeutics Inc.’s shares plummeted the most on record after the company’s experimental drug for the treatment of major depressive disorder failed to show a benefit in a final-stage study. Most Read from Bloomberg Patients who …

Neumora's major depression drug flunks first of three Phase 3 trials

Love Island's Adam Collard reveals 'hardest year' amid addiction and mental health struggle

Former Love Island hunk Adam Collard has bravely spoken out about his battles with addiction and depression, calling 2024 his "hardest year" in a heartfelt Instagram post. Supported by his pregnant fiancée Laura Woods, he reached out with words …

Merck is a new year outlier with its diabetes drug 

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech friends! We’re back with news, including Merck’s decision to cut the price of its diabetes drug Januvia by …

Medications, TMS, and Psychotherapy: A Holistic Approach

For decades, mental health treatment has often followed a linear path: Try one intervention, wait to see if it works, and then try another if it doesn't. This sequential approach can leave patients struggling for months or even years before finding …

Chef sheds 4st by starting controversial diet that has her looking 'so much younger'

A self-taught chef and author of cookbooks has shared her incredible journey to losing four stone, crediting a meat-only 'carnivore' diet for the transformation. Courtney Luna, a TikTok sensation from California, US, dropped an impressive 55 pounds …

Navacaprant for Major Depressive Disorder Fails in Late-Stage Study

The oral kappa opioid receptor antagonist navacaprant for the treatment of major depressive disorder (MDD) has failed in a phase 3 study as part of Neumora Therapeutics' pivotal KOASTAL program.1,2 “We are disappointed by the results from KOASTAL-1 as …

Top Stock Movers Now: Uber, Unity Software, Tesla, and More

CFOTO / Future Publishing via Getty Images People shop for a Tesla car in Yichang, China, on Dec. 31, 2024. U.S. equities edged higher on the first trading day of the new year as optimism about corporate growth in the future was dampened somewhat by …

199 Minutes of Trauma: Oregon Ducks championship dreams go 'up in smoke' vs. Ohio State

On Monday morning, Oregon Ducks senior linebacker Bryce Boettcher sat in a hotel ballroom in downtown Los Angeles and revealed that the team’s theme of the week leading up to the Rose Bowl against the Ohio State Buckeyes was “Up in Smoke.” With two days of …

Stress-related brain inflammation linked to depression

In an interview with the Genomic Press, Professor Raz Yirmiya, a highly respected neuroscientist, discussed how inflammation in the body connects to depression. As the head of the Laboratory for Psychoneuroimmunology at the Hebrew University of Jerusalem, …

Nature’s Richest Omega-3 Source Offers New Hope in Medical Nutrition

New plant-based oil shows life-sustaining promise for critical care patients, sustainable omega-3 wellness for all WINSTON SALEM, NC, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Refined Buglossoides arvensis seed oil, nature’s richest …

EPIC Physical Therapy Announces Opening of Three New Locations in Conjunction with Pickles & Play

New EPIC locations opening in Garner, Wake Forest, and Chapel Hill in January & February 2025 RALEIGH, NC, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- EPIC Physical Therapy, a Raleigh-based physical therapy and sports rehabilitation …

Drug Device Combination Products Market Forecast to Surge to US$ 343.59 Bn Achieving a Remarkable 8.8% CAGR by 2034

The growing existence of diabetes worldwide is a prominent factor driving the drug device combination products market. NEW YORK CITY, NY, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- The drug device combination products market forecast …

Boostlingo Joins athenahealth’s Marketplace Program to Add Interpreting Services Within the EHR

New agreement integrates one of the first on-demand interpreting solutions into athenahealth, providing quick access to medical interpreters in 300+ languages AUSTIN, TX, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Boostlingo, a …

HermannGroup announces agreement with Infinicept to provide go-to-market solutions.

GREENWOOD VILLAGE, CO, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- HermannGroup, a leading boutique advisory firm, today announced a strategic agreement with Infinicept, the pioneer in embedded payments. This collaboration aims to …

Exigent Technologies Launches Augment Co-Managed IT as a Flexible Tech Support Alternative

Managed IT services provider expands portfolio to include collaborative managed services option for larger clients MORRISTOWN, NJ, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Exigent Technologies, a technology services partner committed …

The Brookbush Institute updates the course 'Anterior Oblique Subsystem'

Find out how the rectus abdominis, abdominal fascia, external obliques, and anterior adductors work together to aid in stabilization and movement. NEW YORK, NY, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Excerpt from the course: …

Mitch Gould of Nutritional Products International Celebrates Over 35 Years of Successful Retail Distribution 

BOCA RATON, FL, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Mitch Gould, founder and CEO of Nutritional Products International, is celebrating more than 35 years of successful retail distribution. Gould has been more commonly known as …

Samant Kumar, Capgemini Portfolio Manager, Discusses AI's Role in Agile and Future-Ready Transformation

Exploring AI's transformative impact, Samant Kumar shares insights on agile strategies and innovation for building future-ready enterprises. SAN FRANCISCO, CA, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- In a recent interview with …

Virtual Health Service Market Is Booming Worldwide 2024-2031 | Teladoc Health, Amwell, Doctor on Demand

Global virtual health service market size is projected to reach US$ 78.84 Bn by 2030 from an estimated US$ 11.11 Bn in 2023, exhibiting a CAGR of 32.3%. BURLINGAME, CA, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- This report on the …

Immunoglobulin Market Generated Opportunities, Future Scope by 2024-2031| Baxter international Inc., CSL Ltd.

BURLINGAME, CA, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- According to the latest research from Coherent Market Insights, the Immunoglobulin Market is projected to experience significant growth between 2024 and 2031. This market …

Patient Access Solutions Market Size to Surpass USD 3.61 Billion by 2032 | Share & Growth Analysis

Market Set to Revolutionize Healthcare Accessibility, Enhancing Patient Engagement and Streamlining Revenue Cycles Through Innovative Technology AUSTIN, TX, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- According to Research by SNS …

DR. KINKINI ROY SELECTED AS TOP ASSOCIATE DIRECTOR OF THE YEAR IN FORMULATION DEVELOPMENT BY IAOTP

Dr. Kinkini Roy honored member of the International Association of Top Professionals (IAOTP) will be honored at their annual awards gala in Las Vegas NEW YORK, NY, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Dr. Kinkini Roy was recently …

Autism Behavior Services, Inc. Brings Heartfelt Cheer to Local Shelter with Christmas Gifts

LAKE FOREST,, CA, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- This December, Autism Behavior Services, Inc. (ABSI) partnered with a local shelter for battered women to bring a message of care, compassion, and community at this most …

Center for Plain Language Releases 12th Annual Federal Plain Language Report Card

Federal Agencies Graded on Clear Communication Efforts to Better Serve Citizens RICHMOND, VA, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- The Center for Plain Language released today the 2024 Federal Plain Language Report Card, …

Dr. John DenBoer to Launch Studio Accelerator Focused on Empowering Aging Populations

Dr. John DenBoer to Launch Studio Accelerator Focused on Empowering Aging Populations MILWAUKEE, WI, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Dr. John DenBoer, a renowned innovator in mental health and aging, today announced the …

Alexandrea Masson Launches New Book 'The Complete Gut Health Guide for Women,' a Holistic Path to Wellness

Certified Holistic Health Coach Alexandrea Masson provides practical, science-backed strategies for women to conquer digestive issues without drastic measures UNITED KINGDOM, January 6, 2025 /⁨EINPresswire.com⁩/ -- In an important development for …

As 2025 Begins, Healthcare Costs Remain a Concern for Small Businesses and Families

Billing errors, rising premiums, and cost unpredictability drive demand for transparency, stable pricing, and reform in the evolving healthcare landscape. BRIGHTON, MA, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- With the new year …

Senex Awarded STTR Grant from National Cancer Institute for CDK8/19 Inhibition as Treatment of Metastatic Ovarian Cancer

The grant expands the Company’s focus on women’s health following our recent publication on the importance of CDK8/19 inhibition as treatment for breast cancer COLUMBIA, SC, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Senex …

Rezilient Health and TrueClaim Partner to Improve Access to Quality and Affordable Healthcare

Rezilient Heath and TrueClaim announced the launch of their partnership to bring value-based primary care to more people via employer health benefits. ST. LOUIS, MO, UNITED STATES, January 6, 2025 /⁨EINPresswire.com⁩/ -- Rezilient Heath, a leading …